HELIX BIOPHARMA (Germany) Today
| HBP Stock | EUR 1.15 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 86
|
HELIX BIOPHARMA is selling for under 1.15 as of the 27th of November 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 1.15. HELIX BIOPHARMA has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for HELIX BIOPHARMA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
HELIX Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. HELIX BIOPHARMA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding HELIX BIOPHARMA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Other, Other (View all Sectors) |
HELIX BIOPHARMA (HBP) is traded on Munich Exchange in Germany and employs 13 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 38.94 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HELIX BIOPHARMA's market, we take the total number of its shares issued and multiply it by HELIX BIOPHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. HELIX BIOPHARMA operates under Other sector and is part of Other industry.
HELIX BIOPHARMA generates negative cash flow from operations
Check HELIX BIOPHARMA Probability Of Bankruptcy
HELIX Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in HELIX BIOPHARMA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Additional Tools for HELIX Stock Analysis
When running HELIX BIOPHARMA's price analysis, check to measure HELIX BIOPHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HELIX BIOPHARMA is operating at the current time. Most of HELIX BIOPHARMA's value examination focuses on studying past and present price action to predict the probability of HELIX BIOPHARMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HELIX BIOPHARMA's price. Additionally, you may evaluate how the addition of HELIX BIOPHARMA to your portfolios can decrease your overall portfolio volatility.